Arianna Huffington's Thrive Global partners with Zepbound-maker Eli Lilly to share content on healthy habits where patients ...

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...

The company anticipates 2025 revenue to be in the range of $58.0 billion to $61.0 billion, growth of 32% at the midpoint compared to expected 2024 revenue ...

DETROIT, MI, UNITED STATES, January 13, 2025 /EINPresswire / -- The National Veteran Business Development Council (NVBDC) is excited to announce an exclusive webinar featuring Eli Lilly and Company ...

Eli Lilly and Company (NYSE: LLY) and Scorpion Therapeutics, Inc. ("Scorpion"), a private biotechnology company developing small molecule precision oncology therapies, today announced a definitive ...

Initial data for the Heart-2 Phase 1b clinical trial of VERVE-102 targeting PCSK9 expected in second quarter of 2025Dosing in the Heart-2 trial ...

Eli Lilly (LLY) reduced its fourth-quarter sales guidance by 5%, lowering expectations to $13.5 billion. This figure is $400 ...

Averaging up to 20% of weight loss, adults taking Tirzepatide had at least 25 fewer breathing interruptions each hour as they ...

The Martin Luther King Jr. Celebration Thursday, Jan. 23, at the Show Me Center will spotlight the theme "Against All Odds, ...

Eli Lilly and Company (NYSE: LLY ... For full episodes of Opening Bid, listen on your favorite podcast platform or watch on our website. (Bloomberg) -- Investors seeking the next ...